Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Maintains $226 Price Target
CME Gr Analyst Ratings
CME Group: Strong Buy Rating Amid Robust Trading Volumes and Positive Market Outlook
Barclays Reaffirms Their Hold Rating on CME Group (CME)
Goldman Sachs Adjusts Price Target on CME Group to $192 From $205, Maintains Sell Rating
CME Gr Analyst Ratings
JPMorgan Downgrades CME to Underweight From Neutral, Adjusts Price Target to $187 From $206
Deutsche Bank Adjusts CME Group Price Target to $205 From $210
Analysts Offer Insights on Financial Companies: Upstart Holdings (UPST), CME Group (CME) and Regions Financial (RF)
Komo: Maintaining the CME Gr (CME.US) rating, adjusted from neutral to neutral, and adjusted the target price from $198.00 to $206.00.
Analysts Offer Insights on Financial Companies: CME Group (CME) and Synchrony Financial (SYF)
CME Gr Analyst Ratings
Rosenblatt Reiterates Sell on CME Gr, Raises Price Target to $187
Analysts Have Conflicting Sentiments on These Financial Companies: GooseHead Insurance (GSHD), Raymond James Financial (RJF) and CME Group (CME)
Goldman Sachs Adjusts Price Target on CME to $205 From $201
KBW Reaffirms Their Hold Rating on CME Group (CME)
Piper Sandler Sticks to Its Buy Rating for CME Group (CME)
Damo: Maintaining the CME Gr (CME.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $222.00 to $225.00.
CME Gr Analyst Ratings
Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $225